Plain-English translation of NCT04124341 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing Prefrontal Cortical Stimulation (PCS), a surgically implanted device that delivers electrical stimulation to a specific area of the brain to treat severe depression. You would receive the implant if you have struggled with depression for at least 2 years and haven't found relief from four or more different antidepressant medications. The treatment aims to reduce depression symptoms in ways that traditional medications alone have not been able to achieve.
Many people with severe depression do not respond adequately to standard antidepressant medications, leaving them with limited options for treatment. This trial exists to test whether direct brain stimulation using this implanted device can provide meaningful and lasting relief for these patients.
You likely qualify if…
You likely don't qualify if…
You would first complete a 2-week baseline period with medical exams, blood work, and brain imaging to confirm you are eligible. If eligible, you would be hospitalized for at least 3 days for surgery to implant the device. Over the next 19 weeks, you would attend 10 follow-up visits where doctors assess your depression and adjust the stimulation settings while monitoring your brain activity. After that, you would continue monthly visits for 7 months, and then quarterly visits (either in-person or by video) for up to 4 years to track your progress and ensure the device is working well.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States